PRESS RELEASEREGULATED INFORMATION23 April 2024, 07:00 am CET Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 23 May 2024 Publication of Annual Report 2023...
PRESS RELEASEREGULATED INFORMATION “ INSIDE INFORMATION28 March 2024, 08:00 a.m. CET alfapump® “ PMA1 submitted to US FDA and accepted for substantive review, extensive feedback just received from...
MOJAVE “ US Phase 1/2a study of DSR 2.0 for treatment of heart failure Previously reported strong data maintained after three-months follow-up: Diuretic response remained nearly normalized, with a...
THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED...